Its triple-receptor mechanism adds glucagon-mediated energy expenditure that the other two lack
Read the full story: To view or add a comment, sign in The ASA and CAP have released a new consumer research report and enforcement report, following growing public consciousness surrounding GLP-1 weight loss medications
Yes, when you stop tirzepatide, you may regain weight
Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of the DEGs revealed that many were involved in inflammation (Fig
The percentage of individuals with a weight reduction of 5% was 85%, 89%, and 91% with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% with placebo
Benefits Weight loss (due to calorie loss through glucose in urine) Mild blood pressure reduction Cardio-renal protection Side Effects Increased urination Genital or urinary tract infections (due to excess sugar in urine) Dehydration or low blood pressure Ketoacidosis (rare but serious) even with normal blood sugar Contraindications / Caution Type 1 Diabetes (risk of ketoacidosis) Severe kidney disease (low eGFR) Recurrent urinary tract or fungal infections Dehydration risk Key Point Dapagliflozin not only lowers blood sugar but also protects the heart and kidneys making it valuable beyond diabetes control
